📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

High throughput application of the NanoBiT Biochemical Assay for the discovery of selective inhibitors of the interaction of PI3K-p110a with KRAS. (2024)

First Author: Ismail M

Attributed to: Cancer drug discovery targeting the interaction of RAS oncogenic proteins with phosphoinositide 3-kinase funded by UKRI Inn.Scholar

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.slasd.2024.100197

PubMed Identifier: 39613028

Publication URI: http://europepmc.org/abstract/MED/39613028

Type: Journal Article/Review

Volume: 29

Parent Publication: SLAS discovery : advancing life sciences R & D

Issue: 8

ISSN: 2472-5552